Amplitude Therapeutics
PrivateLast Round
Grant
Nov 1, 2024
Total Funding Raised
$3.77M
Company Overview
Amplitude Therapeutics is a biotechnology company that develops ribonucleic acid medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amplitude Therapeutics Comparables
Compare Amplitude Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Replicate Bioscience | 83% | |
| Ziphius Vaccines | 80% | |
| Eli Lilly and Company | 77% |
Amplitude Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2024 | ||||
| Grant | Aug 20, 2024 | ||||
| Grant | Mar 7, 2024 | ||||
| Seed | Mar 7, 2024 |
Amplitude Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newpath Partners | Seed |
| CEPI | Grant |
| ARCH Venture Partners | Seed |
| Administration for Strategic Preparedness and Response | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Alta Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2024
Secured $2.04M in grant funding.
- Aug 20, 2024
$733K grant round completed.
Recent news
Latest coverage and updates
- partners_withAug 21, 2026
Amplitude partnered with Lilly Group on Aug 19th '26.
- is_developingAug 21, 2026
Amplitude is developing taRNA vaccines for infectious diseases on Aug 21st '26.
Amplitude Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Amplitude Therapeutics's valuation, stock price, and market status.
Is Amplitude Therapeutics a public or private company?
Amplitude Therapeutics is a private company.
What is the current stock price of Amplitude Therapeutics?
Amplitude Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Amplitude Therapeutics worth (valuation)?
Valuation information for Amplitude Therapeutics is not publicly available.
Can I buy Amplitude Therapeutics stock?
Amplitude Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Amplitude Therapeutics's last funding round?
Amplitude Therapeutics's most recent funding round was Grant on November 1, 2024.
Who are the main investors in Amplitude Therapeutics?
Key investors in Amplitude Therapeutics include ARCH Venture Partners, Alta Partners.
Will Amplitude Therapeutics IPO soon?
No public IPO plans have been announced for Amplitude Therapeutics.
How can I track Amplitude Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amplitude Therapeutics's secondary market activity and sign up for updates.